Bharat Book Bureau Provides the Trending Market Research Report on “Global Infectious Diseases in Vitro Diagnostics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028” under Life Sciences Market Research Reports Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.
Global Infectious Diseases In-Vitro Diagnostics (Ivd) Market is valued at approximately USD 54 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 3.8% over the forecast period 2020-2027. Infectious Diseases in-Vitro Diagnostics (IVD) is a type of medical devices, which needs the use of reagents and assays to treat a medical condition. The information shown through these diagnostic tools helps physicians in productive management of medical settings in each stage.
The regional analysis of the global Infectious Diseases in-Vitro Diagnostics (IVD) market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising demand for the Point-of-care and molecular diagnostic devices, along with the rise in presence of market vendors in the region. Whereas, Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as growing prevalence of infectious diseases along with growing healthcare infrastructure in developing countries, such as China and India, are the few factors creating lucrative growth opportunities for the Infectious Diseases in-Vitro Diagnostics (IVD) market in the region.
Major market player included in this report are:
Becton, Dickinson and Company
BioMérieux SA
Abbott Laboratories
Quidel Corporation
OraSure Technologies, Inc.
Hologic Inc. (Gen Probe)
Qiagen
F. Hoffmann-La Roche Ltd.
Siemens Healthcare GmbH
Bio-Rad Laboratories, Inc.
The detailed segments and sub-segment of the market are explained below:
By Product:
Instruments
Reagent
Services
By Technology:
Immunoassay
Molecular Diagnostics
Microbiology
Others
By Application:
Streptococcus
Clostridium Difficile
Carbapenem-resistant enterobacterial testing (CRE)
Respiratory virus
Tuberculosis (TB) & drug-resistant TB
Human Immunodeficiency Virus (HIV)
Gonorrhea
Chlamydia
Others
By End-Use:
Point of Care
Central Laboratories
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027
Target Audience of the Global Infectious Diseases in-Vitro Diagnostics (IVD) Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Browse our full report with Table of Content :
About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.
Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: [email protected]
Website: www.bharatbook.com
The global infectious diseases in vitro diagnostics market size is estimated to reach USD 33.1 billion by 2027, according to a new report by Radiant Insights, Inc., registering a CAGR of 6.3% over the forecast period.
Moreover, although most diagnostics are specific to an application, upcoming diagnostic products would be able to test and confirm multiple related diseases, thus saving time and money.
Download Free Sample Report @ https://www.radiantinsights.com/research/ivd-infectious-disease-market/request-sample Presence of various e-commerce sites offering diagnostic kits, especially Point of Care (PoC) devices, is expected to drive the sales of the products through this sales channel.
Moreover, the regulatory and reimbursement landscape is continually evolving to adapt to the fast-paced research progress in this sector.
Proactive initiatives by public and private organizations to raise consumer awareness about infectious diseases and treatment modalities are expected to drive the market growth in the coming years.
Further key findings from the report suggest: • Technological advancements related to accuracy, portability, and cost-effectiveness are expected to be high impact rendering drivers for the market • Growing awareness and increasing dependency of healthcare practitioners on the usage of point-of-care diagnostic enabled medical devices and consumables are expected to drive the IVD infectious diseases market growth over the forecast period • Key applications of immunochemistry include detection of infectious microorganisms such as virus, bacteria, and fungus and their toxins and coat antigens • Development of techniques such as Polymerase Chain Reaction (PCR) and in-situ hybridization is expected to boost the molecular diagnostics segment over the forecast period • Key players include bioMérieux SA; BD; Abbott; Quidel Corporation; F. Hoffmann-La Roche Ltd.; Alere Inc.; Cepheid; Hologic Inc.; Qiagen N.V.; Orasure Technologies, Inc.; Bio-Rad Laboratories, Inc.; and Siemens Healthcare GmbH.
